Citius Pharma (CTXR) Becomes Revenue-Generating With the Commercial Launch of LYMPHIR

7 3 月, 2026

One Min Read

12 Views

原文: https://finance.yahoo.com/news/citius-pharma-ctxr-becomes-revenue-200027051.html

Last Update: 7 3 月, 2026

Written By

Other Articles

Previous

Eaton (ETN) Appoints David Foster as EVP and CFO Following 2025 Financial Results

Next

Webull (BULL) Reports 2025 Revenue of $571M, 46% YoY Growth

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept